ADC
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
Agree Realty Corporation
- Nom
- Agree Realty Corporation
- Secteur
- Real Estate
- Industrie
- REIT - Retail
- Bourse
- NYSE
- Capitalisation
- $8.3B
- Employés
- 90
- PDG
- Joel N. Agree
- Site web
- https://www.agreerealty.com
- Marché
- BRXCDR-PCEPRTGTYNNNO
Agree Realty Corporation functions as a publicly traded Real Estate Investment Trust (REIT), concentrating its efforts on the acquisition and development of commercial properties. These assets are primarily net-leased to leading companies within the retail sector. As of September 30, 2020, the firm oversaw a substantial portfolio of 1,027 properties, which were distributed across 45 U.S. states and encompassed a total gross leasable area of approximately 21.0 million square feet. Shares of Agree Realty's common stock are available for trade on the New York Stock Exchange, identified by the ticker symbol ADC.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
ACHAT TOTAL: 20136 titres (~1474599 USD)
- Insiders
- RAKOLTA JOHN JR
- Total bought
-
$1,474,599
Avg buy (VWAP, 90d window) $70.82 vs last close $66.70 (-5.8%)
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-28
- Liquidity
- Liquid $118,896,295/day · 20d vol
- Last synced
-
2026-10-23 21:10:03
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-21 | Erlich Craig | Buy · P | 1,000 | $67.55 | $67,550 | Form 4 |
| 2026-09-16 | Agree Joey | Buy · P | 7,360 | $68.06 | $500,922 | Form 4 |
| 2026-09-16 | RAKOLTA JOHN JR | Buy · P | 20,000 | $68.78 | $1,375,600 | Form 4 |
| 2026-08-31 | RAKOLTA JOHN JR | Buy · P | 10,000 | $72.42 | $724,200 | Form 4 |
| 2026-08-28 | RAKOLTA JOHN JR | Buy · P | 136 | $73.52 | $9,999 | Form 4 |
| 2026-08-27 | RAKOLTA JOHN JR | Buy · P | 20,000 | $73.23 | $1,464,600 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-01 | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2026-01-15 | Gilbert Cisneros | Sale (Full) | $15,001 - $50,000 |
| 2025-09-25 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-08-13 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-11 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-04-09 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-04-15 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-03-14 | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2023-07-12 | Daniel Goldman | Sale (Full) | $1,001 - $15,000 |
| 2020-09-29 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-07-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-07-22 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2019-03-25 | Van Taylor | Sale (Full) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
ADC presents a meaningful event-driven signal — a significant insider cluster buy (~$1.47M) amid a 17% stock pullback — which historically correlates with near-term price recovery in REIT names with stable cash flows.
The first sentence of the analysis written for ADC on 2026-10-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Neutral signal
Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Unavailable or mixed. Current ratio 0.83 · operating margin 47% — readings disagree
Suggested stop 63.74, nearest stored support minus 0.5 ATR(4.4% under the last close). Reward/risk to the next stored resistance is 0.13. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-19 3 Dividend Stocks That Let You Collect Rent Without Becoming a Landlord Net lease REITs let you collect rent checks without fixing a single leaky faucet, but not all three of these monthly payers carry the same risks, growth rates, or tenant quality under the hood.
- 2026-10-19 Agree Realty Corporation After The Rate Hike: Buy, Hold, Or Sell? Agree Realty has crashed 17% despite strong fundamentals. Its fortress balance sheet limits the impact of rising rates. Insiders are buying heavily, even as the stock gets cheaper.
- 2026-10-19 Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform Montreal, Quebec--(Newsfile Corp. - October 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce two significant achievements at World ADC San Diego 2026, held October 12-15: winning the conference''s Best Poster Award for its Accum ® -ADC research and leading a main-stage discussion alongside internationally recognized experts in antibody-drug conjugates ("ADCs"). These achievements highlight the growing recognition of Defence''s Accum® technology within the global ADC community.
- 2026-10-18 ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast CancerPR NewswireSHANGHAI, O
- 2026-10-18 /C O R R E C T I O N - AbbVie/ /C O R R E C T I O N - AbbVie/PR NewswireNORTH CHICAGO, Ill., Oct. 18, 2026In the news release, AbbVie to Present Data at the 2026 European Society for Medical
- 2026-10-18 AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor PortfolioPR News
- 2026-10-18 Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) CongressPR NewswireINDIANAPOLIS, Oct. 18, 2026F
- 2026-10-18 Dividend Announcements: October 10-16, 2026 I track dividend announcements across 1,200+ stocks. This week, I''m highlighting 12 dividend increases and 2 specials. LECO stands out with a 10.13% dividend increase, the highest Quality Score (8.54), and a 30-year streak, though it trades at fair value. IBKR posted a 71.43% dividend hike and leads in Dividend Safety (9.2), but offers a low 0.73% forward yield and weak financial strength.
- 2026-10-18 AI Reality Check, Inflation Stress Test U.S. equities stumbled as AI-bubble concerns overwhelmed otherwise resilient fundamentals, while September inflation ran hot but remained heavily energy-driven, complicating the Fed''s path without clearly forcing an October hike. Treasuries rallied sharply despite hotter CPI and PPI, with the 2-Year reversing from 4.95% to 4.71% as dovish Fed signals and risk-off flows pushed October hike odds. Oil reemerged as the key macro pressure point, with WTI surging above $100 as Saudi and Hormuz risks intensified, threatening to reverse recent relief in gasoline and diesel prices.
- 2026-10-17 5 Monthly Dividend Stocks Retirees Should Consider This Month Monthly bills arrive on a schedule that quarterly dividends cannot match, but five stocks pay 12 times a year with yields climbing as high as 6.65%. Two of them carry risks that could quietly shrink your paycheck before you notice.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 87.7% | 87.9% | 87.6% | 87.8% | 87.9% | |
| Ebit Margin | 47.5% | 49.1% | 47.4% | 51.0% | 51.8% | |
| Ebitda Margin | 85.9% | 88.0% | 86.3% | 89.9% | 87.1% | |
| Operating Profit Margin | 47.4% | 49.0% | 47.3% | 50.7% | 56.1% | |
| Pretax Profit Margin | 28.8% | 31.5% | 32.3% | 36.3% | 36.9% | |
| Continuous Operations Profit Margin | 28.5% | 30.8% | 31.7% | 35.6% | 36.2% | |
| Net Profit Margin | 28.4% | 30.7% | 31.6% | 35.5% | 36.0% | |
| Bottom Line Profit Margin | 27.3% | 29.4% | 30.2% | 33.6% | 35.3% | |
| Current Ratio | 0.834 | 0.783 | 0.797 | 0.893 | 1.201 | |
| Quick Ratio | 0.834 | 0.783 | 0.797 | 0.893 | 1.201 | |
| Solvency Ratio | 0.136 | 0.144 | 0.147 | 0.153 | 0.134 | |
| Cash Ratio | 0.095 | 0.044 | 0.086 | 0.262 | 0.498 | |
| Price To Earnings Ratio | 40.695 | 39.358 | 37.029 | 38.549 | 39.866 | |
| Price To Earnings Growth Ratio | -36.422 | 7.434 | -4.867 | 13.801 | 23.388 | |
| Forward Price To Earnings Growth Ratio | -36.422 | 7.434 | -4.867 | 13.801 | 23.388 | |
| Price To Earnings Diluted Ratio | 40.695 | 39.579 | 37.029 | 38.760 | 40.090 | |
| Price To Earnings Diluted Growth Ratio | -72.437 | 8.410 | -5.213 | 13.798 | 17.439 | |
| Price To Book Ratio | 1.272 | 1.293 | 1.153 | 1.205 | 1.395 | |
| Price To Sales Ratio | 11.102 | 11.542 | 11.149 | 12.981 | 14.049 | |
| Price To Free Cash Flow Ratio | 15.820 | 16.488 | 15.302 | 15.407 | 19.353 | |
| Price To Operating Cash Flow Ratio | 15.820 | 16.488 | 15.302 | 15.407 | 19.353 | |
| Debt To Assets Ratio | 0.342 | 0.334 | 0.315 | 0.294 | 0.360 | |
| Debt To Equity Ratio | 0.535 | 0.514 | 0.471 | 0.427 | 0.550 | |
| Debt To Capital Ratio | 0.349 | 0.339 | 0.320 | 0.299 | 0.355 | |
| Long Term Debt To Capital Ratio | 0.344 | 0.336 | 0.317 | 0.295 | 0.331 | |
| Financial Leverage Ratio | 1.562 | 1.540 | 1.495 | 1.450 | 1.529 | |
| Working Capital Turnover Ratio | -24.050 | -21.609 | -28.951 | 139.437 | -16.356 | |
| Operating Cash Flow Ratio | 2.939 | 2.997 | 3.085 | 3.414 | 2.835 | |
| Operating Cash Flow Sales Ratio | 0.702 | 0.700 | 0.729 | 0.843 | 0.726 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | |
| Debt Service Coverage Ratio | 4.571 | 4.949 | 5.683 | 6.044 | 1.394 | |
| Interest Coverage Ratio | 2.529 | 2.775 | 3.136 | 3.438 | 3.777 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 1.539 | |
| Operating Cash Flow Coverage Ratio | 0.150 | 0.153 | 0.160 | 0.183 | 0.131 | |
| Capital Expenditure Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividend Paid And Capex Coverage Ratio | 1.448 | 1.389 | 1.373 | 1.590 | 1.258 | |
| Dividend Payout Ratio | 1.703 | 1.644 | 1.678 | 1.494 | 1.602 | |
| Enterprise Value Multiple | 18.335 | 18.311 | 18.168 | 19.491 | 22.337 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 87.7% | ▼-0.1% | ▼-0.1% |
| Ebit Margin | 47.5% | ▼-1.6% | ▼-1.8% |
| Ebitda Margin | 85.9% | ▼-2.1% | ▼-1.6% |
| Operating Profit Margin | 47.4% | ▼-1.6% | ▼-2.7% |
| Pretax Profit Margin | 28.8% | ▼-2.7% | ▼-4.4% |
| Continuous Operations Profit Margin | 28.5% | ▼-2.2% | ▼-4.0% |
| Net Profit Margin | 28.4% | ▼-2.2% | ▼-4.0% |
| Bottom Line Profit Margin | 27.4% | ▼-2.0% | ▼-3.8% |
| Current Ratio | 0.834 | ▲0.051 | ▼-0.067 |
| Quick Ratio | 0.834 | ▲0.051 | ▼-0.067 |
| Solvency Ratio | 0.136 | ▼-0.008 | ▼-0.007 |
| Cash Ratio | 0.095 | ▲0.051 | ▼-0.102 |
| Price To Earnings Ratio | 40.695 | ▲1.337 | ▲1.596 |
| Price To Earnings Growth Ratio | -36.422 | ▼-43.856 | ▼-37.089 |
| Forward Price To Earnings Growth Ratio | -36.422 | ▼-43.856 | ▼-37.089 |
| Price To Earnings Diluted Ratio | 40.695 | ▲1.116 | ▲1.464 |
| Price To Earnings Diluted Growth Ratio | -72.437 | ▼-80.847 | ▼-64.837 |
| Price To Book Ratio | 1.272 | ▼-0.021 | ▲0.008 |
| Price To Sales Ratio | 11.102 | ▼-0.440 | ▼-1.063 |
| Price To Free Cash Flow Ratio | 15.820 | ▼-0.668 | ▼-0.654 |
| Price To Operating Cash Flow Ratio | 15.820 | ▼-0.668 | ▼-0.654 |
| Debt To Assets Ratio | 0.342 | ▲0.009 | ▲0.013 |
| Debt To Equity Ratio | 0.535 | ▲0.021 | ▲0.036 |
| Debt To Capital Ratio | 0.348 | ▲0.009 | ▲0.016 |
| Long Term Debt To Capital Ratio | 0.344 | ▲0.009 | ▲0.020 |
| Financial Leverage Ratio | 1.562 | ▲0.022 | ▲0.047 |
| Working Capital Turnover Ratio | -24.050 | ▼-2.441 | ▼-33.744 |
| Operating Cash Flow Ratio | 2.939 | ▼-0.059 | ▼-0.115 |
| Operating Cash Flow Sales Ratio | 0.702 | ▲0.002 | ▼-0.038 |
| Free Cash Flow Operating Cash Flow Ratio | 1.000 | 0.000 | 0.000 |
| Debt Service Coverage Ratio | 4.571 | ▼-0.378 | ▲0.043 |
| Interest Coverage Ratio | 2.529 | ▼-0.247 | ▼-0.602 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | ▼-0.308 |
| Operating Cash Flow Coverage Ratio | 0.150 | ▼-0.002 | ▼-0.005 |
| Capital Expenditure Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Dividend Paid And Capex Coverage Ratio | 1.448 | ▲0.059 | ▲0.037 |
| Dividend Payout Ratio | 1.703 | ▲0.059 | ▲0.079 |
| Enterprise Value Multiple | 18.335 | ▲0.025 | ▼-0.993 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $7.98B | $7.12B | $5.99B | $5.58B | $4.77B | |
| Enterprise value | $11.31B | $9.95B | $8.43B | $7.53B | $6.60B | |
| EV / Sales | 15.75x | 16.12x | 15.68x | 17.52x | 19.46x | |
| EV / Op. cash flow | 22.44x | 23.03x | 21.52x | 20.79x | 26.81x | |
| EV / Free cash flow | 22.44x | 23.03x | 21.52x | 20.79x | 26.81x | |
| EV / EBITDA | 18.34x | 18.31x | 18.17x | 19.49x | 22.34x | |
| Net debt / EBITDA | 5.41x | 5.20x | 5.25x | 5.05x | 6.21x | |
| Current ratio | 0.83x | 0.78x | 0.80x | 0.89x | 1.20x | |
| Income quality | 2.46x | 2.28x | 2.30x | 2.37x | 2.00x | |
| Graham number | $48 | $48 | $47 | $51 | $46 | |
| Graham net-net | -$31 | -$29 | -$26 | -$25 | -$26 | |
| Tax burden | 98.9% | 97.5% | 98.0% | 97.8% | 97.6% | |
| Interest burden | 60.6% | 64.1% | 68.1% | 71.1% | 71.3% | |
| Working capital | -$28.4M | -$31.3M | -$25.8M | -$11.3M | $17.5M | |
| Invested capital | $972.5M | $833.6M | $828.3M | $788.1M | $689.5M | |
| Return on assets | 2.1% | 2.2% | 2.2% | 2.3% | 2.3% | |
| Operating ROA | 3.7% | 3.7% | 3.5% | 3.7% | 4.2% | |
| Return on tangible assets | 2.3% | 2.5% | 2.5% | 2.6% | 2.7% | |
| Return on equity | 3.3% | 3.4% | 3.3% | 3.3% | 3.6% | |
| Return on invested capital | 3.5% | 3.5% | 3.3% | 3.2% | 3.5% | |
| Return on capital employed | 3.5% | 3.6% | 3.3% | 3.3% | 3.7% | |
| Earnings yield | 2.6% | 2.7% | 2.8% | 2.7% | 2.6% | |
| Free cash flow yield | 6.3% | 6.1% | 6.5% | 6.5% | 5.2% | |
| Capex / Op. cash flow | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Capex / Depreciation | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Capex / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| SG&A / Sales | 6.1% | 6.0% | 6.5% | 7.0% | 7.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.8% | 1.8% | 1.6% | 1.5% | 1.6% | |
| Intangibles / Total assets | 10.2% | 10.2% | 11.0% | 11.9% | 12.9% | |
| Days sales outstanding | 62d | 63d | 56d | 56d | 57d | |
| Days payables outstanding | 577d | 567d | 555d | 585d | 622d | |
| Operating cycle | 62d | 63d | 56d | 56d | 57d | |
| Cash conversion cycle | -515d | -504d | -498d | -529d | -565d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+12.0%EV / Sales ▼-2.3%EV / EBITDA ▲+0.1%EV / Op. cash flow ▼-0.586Earnings yield ▼-0.001Graham number ▲+0.591
Profitability
Return on equity ▼-0.002Return on assets ▼-0.001Return on invested capital -0.000Return on capital employed ▼-0.001Operating ROA +0.000Income quality ▲+0.184Tax burden ▲+0.014
Efficiency
Days sales outstanding ▼-0.716Days payables outstanding ▲+10.159Operating cycle ▼-0.716Cash conversion cycle ▼-10.875Capex / Sales n/aR&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.051Net debt / EBITDA ▲+0.210Working capital ▲+2857000.000Invested capital ▲+138887000.000Intangibles / Total assets +0.000
Change over 5 years
Valuation
Market cap ▲+67.3%EV / Sales ▼-19.1%EV / EBITDA ▼-17.9%EV / Op. cash flow ▼-4.371Earnings yield -0.000Graham number ▲+2.594
Profitability
Return on equity ▼-0.003Return on assets ▼-0.003Return on invested capital -0.000Return on capital employed ▼-0.002Operating ROA ▼-0.005Income quality ▲+0.455Tax burden ▲+0.012
Efficiency
Days sales outstanding ▲+4.741Days payables outstanding ▼-45.127Operating cycle ▲+4.741Cash conversion cycle ▲+49.868Capex / Sales n/aR&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.367Net debt / EBITDA ▼-0.804Working capital ▼-45925000.000Invested capital ▲+283022000.000Intangibles / Total assets ▼-0.026